Back to Search Start Over

P36 BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST ONE PROTEASOME INHIBITOR, ONE IMMUNOMODULATORY AGENT AND ONE ANTI-CD38 MONOCLONAL ANTIBODY: A RETRO-PROSPECTIVE ITALIAN OBSERVATIONAL STUDY

Details

Language :
English
ISSN :
25729241
Volume :
7
Issue :
S2
Database :
Directory of Open Access Journals
Journal :
HemaSphere
Publication Type :
Academic Journal
Accession number :
edsdoj.00308eb631d645568fb0bef3917aef9a
Document Type :
article
Full Text :
https://doi.org/10.1097/01.HS9.0000936272.88286.72